On Wednesday, Triveni Bio became the latest immunology and inflammation startup this year to announce a $100 million-plus ...

Jim Collins, the famed MIT professor and a godfather of the synthetic biology field, describes Felix Wong as one of the most ...

LoQus23 Therapeutics has secured £35 million ($43 million) in a Series A fundraise backed by the venture arm of Novartis to ...

GSK's ViiV Healthcare has suspended development of a Phase 2-stage HIV antiviral named VH3739937, a GSK spokesperson ...

A New York federal judge has denied Amgen’s motion to dismiss a class action lawsuit alleging the company misled investors ...

Senators may be back in their districts gearing up for next month's elections, but that isn't stopping them from questioning ...

Enliven Therapeutics released new Phase 1 data for its chronic myeloid leukemia program (CML) it hopes can eventually compete ...

Months after announcing the failure of a mid-stage trial for its personalized neoantigen vaccine in cancer, Gritstone bio ...

Struggling healthcare giant CVS Health is considering breaking up the company, including separating its pharmacy and ...

Plus, news about IN8bio, Sanofi, Vicore Pharma, Cartherics, Zephyrm Bioscience, Tharimmune and Intract Pharma: Biohaven’s $250M offering: The move comes after Biohaven announced Monday that it started ...

Shattuck Labs is laying off 40% of its workforce and discontinuing its CD47 program in acute myeloid leukemia and higher-risk ...

Obesity startup Metsera is getting a new manufacturing partner and a new CEO. On Tuesday, the well-funded startup announced ...